Goldman Sachs
-
Goldman Sachs Its subsidiary, Marcus, offers today’s highest CD rates, with an annualized yield of 4.10% on a 9-month CD.
As of August 2, 2026, the annualized yield (APY) on the 9-month certificate of deposit (CD) offered by Marcus, a subsidiary of Goldman Sachs (Goldman Sachs), reached 4.10%, marking the highest interes
-
Goldman Sachs Analysis: Crowded Trades in U.S. Stocks Took a Heavy Hit in July; Calm Indexes Mask Underlying Volatility; The Bull Market Continues, but the Outlook Is More Challenging
Goldman Sachs Tony Pasquariello, head of hedge fund strategy, noted in his latest market commentary that while U.S. stock indices appeared calm in July (with the S&P 500 trading within a range of just
-
Goldman Sachs Cuts Apple Price Target to $360 on Softer Outlook
Goldman Sachs has lowered its price target for Apple (AAPL) to $360 from $370, while maintaining a Buy rating. The firm cited weaker-than-expected Q4 guidance on revenue growth and margins as the reas
-
Goldman Sachs Trader: U.S. stocks lack the momentum for a meaningful breakout
Goldman Sachs Traders say the U.S. stock market lacks the momentum needed to make a meaningful breakout. Over the past two months, investors have been unable to find clear signals to break the deadloc
-
Goldman Sachs Warning: The market remains in the “ruins of post-deleveraging”; it is recommended to proactively establish protective positions.
Goldman Sachs On July 29, a top trading team warned that although the deleveraging process is nearing its end, market risks have not yet been fully resolved, and multiple key events will continue to s
-
Goldman Sachs Co-Chief Investment Officer: The Market Is Punishing Hyperscale Companies Due to Uncertainty Over AI Returns
Goldman Sachs Alexis Wilson-Elizondo, Co-Head of Global Multi-Asset Solutions and Co-Chief Investment Officer, said the market is punishing megacap companies due to uncertainty surrounding the return
-
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases, is seeking to raise as much as $212.5 million in a US initial public offering. The company is backed by Go
-
Goldman Sachs: Trading Congestion in AI Stocks Falls to a Near-One-Year Low; Market Focus Shifts to Fundamentals
Goldman Sachs Traders noted that trading congestion in global AI-related stocks has fallen to a near one-year low following a round of sharp deleveraging. Goldman Sachs Prime Brokerage data shows that
-
Goldman Sachs: Fed's Decision Today Could Be Largest 'Surprise' Since 1997
Goldman Sachs stated that whatever the U.S. Federal Reserve decides today will mark the largest "surprise" at a non-rate-cut meeting since 1997. This assessment comes as interest-rate futures markets
-
Former Goldman Sachs Banker Berko on Trial for Allegedly Paying Bribes in Ghana
A former Goldman Sachs Group Inc. banker went on trial Tuesday in the US for allegedly paying Ghanaian government officials a “holy rain” of bribes. The bribes were reportedly to secure a lucrative po
-
Goldman Sachs Predicts Big Tech Will Fund Over a Third of AI Investments with Debt by 2027
Goldman Sachs predicts that by 2027, major tech companies, or "hyperscalers," will fund over a third of their artificial intelligence (AI) investments with debt. The firm expects these companies to is
-
Goldman Sachs: Global Hedge Funds Post 7% H1 Returns, Poised for Stellar Year on AI Boom
Global hedge funds returned an average of 7% in the first half of 2026, significantly outperforming their 10-year average of 4.1%, according to a Goldman Sachs report. The bank attributes this strong
-
Goldman Sachs Warns of Rising Macro Risks, Raises US & European Default Forecasts
Goldman Sachs has warned that rising oil volatility is shifting investor focus from company earnings to broader macro risks, including inflation and higher interest rates. The bank expects the Federal
-
Oil Startup Backed by Ex-Goldman Commodity Chief Jeff Currie to IPO in London, Seeking $67 Million
An oil startup backed by Jeff Currie, former Goldman Sachs Group Inc. commodities chief, is preparing to raise £50 million ($67 million) through a London stock market listing. The funds are intended t
-
JPMorgan and Goldman Sachs CEOs Express Caution Despite Record Quarters
JPMorgan and Goldman Sachs recently reported record-breaking quarterly results. However, the CEOs of both firms have expressed uncertainty about the sustainability of these strong performances.
-
Goldman Sachs maintains Q3 2026 TTF gas forecast at €60/MWh, warns of upside risks
Goldman Sachs maintained its Q3 2026 TTF gas forecast at €60/MWh, but noted that risks remain skewed to the upside. The firm indicated that if U.S.-Iran talks succeed, prices could fall below €50/MWh.
-
Goldman Sachs CEO: Supports Advancing the CLARITY Act; the Bill Is Not Perfect
Svmuu News: David Solomon, CEO of Goldman Sachs, expressed support for advancing the CLARITY Act, while acknowledging that the legislation “is not perfect.” His remarks contrast with criticism from JP
-
Goldman Sachs Expressed support for the CLARITY Act, stating that it will establish a fair regulatory framework for the crypto market
Svmuu News Goldman Sachs Group CEO David Solomon stated that although the CLARITY Act is not perfect, he supports its passage, believing it will establish a clearer and fairer regulatory framework for
-
Goldman Sachs: If the Strait of Hormuz remains blocked, Brent crude could rise above $120 in the fourth quarter
Svmuu News Goldman Sachs The group released a report stating that if disruptions in the Strait of Hormuz continue, Brent crude prices could rise above $120 per barrel in the fourth quarter. However, G
-
Goldman Sachs: Hedge Funds Are Dumping U.S. Tech Stocks at a Record Pace
Svmuu News: According to market reports, Goldman Sachs states that hedge funds are selling off U.S. tech stocks at a record pace. (Jin Shi)
-
Spot gold has fallen back below $3,970 per ounce
Svmuu News: According to Gate data, spot gold has fallen back below $3,970 per ounce, down 0.16% on the day. Goldman Sachspreviously noted that, despite pressure from expectations of a hawkish Federal
-
Goldman Sachs: Central Bank Buying Will Support Gold Prices
Svmuu News Goldman Sachs reports that, despite pressure from expectations of a hawkish Federal Reserve, central bank buying is expected to provide support for gold prices.Demand remains strong; accord
-
Goldman Sachs U.S. stocks are expected to see a strong earnings season, with second-quarter earnings for S&P 500 components set to surge 22% year-over-year.
Svmuu News: According to Goldman Sachs, the U.S. stock market is set to see another strong earnings season. Goldman Sachs Earnings for S&P 500 components are projected to surge 22% year-over-year in t
-
Goldman Sachs Robinhood's target price raised to $137
Svmuu News: Goldman Sachs has raised its price target for Robinhood from $121 to $137 and maintained its “Buy” rating.
-
Goldman Sachs Its subsidiary, Marcus, offers today’s highest CD rates, with an annualized yield of 4.10% on a 9-month CD.
As of August 2, 2026, the annualized yield (APY) on the 9-month certificate of deposit (CD) offered by Marcus, a subsidiary of Goldman Sachs (Goldman Sachs), reached 4.10%, marking the highest interes
-
Goldman Sachs Analysis: Crowded Trades in U.S. Stocks Took a Heavy Hit in July; Calm Indexes Mask Underlying Volatility; The Bull Market Continues, but the Outlook Is More Challenging
Goldman Sachs Tony Pasquariello, head of hedge fund strategy, noted in his latest market commentary that while U.S. stock indices appeared calm in July (with the S&P 500 trading within a range of just
-
Goldman Sachs Cuts Apple Price Target to $360 on Softer Outlook
Goldman Sachs has lowered its price target for Apple (AAPL) to $360 from $370, while maintaining a Buy rating. The firm cited weaker-than-expected Q4 guidance on revenue growth and margins as the reas
-
Goldman Sachs Trader: U.S. stocks lack the momentum for a meaningful breakout
Goldman Sachs Traders say the U.S. stock market lacks the momentum needed to make a meaningful breakout. Over the past two months, investors have been unable to find clear signals to break the deadloc
-
Goldman Sachs Warning: The market remains in the “ruins of post-deleveraging”; it is recommended to proactively establish protective positions.
Goldman Sachs On July 29, a top trading team warned that although the deleveraging process is nearing its end, market risks have not yet been fully resolved, and multiple key events will continue to s
-
Goldman Sachs Co-Chief Investment Officer: The Market Is Punishing Hyperscale Companies Due to Uncertainty Over AI Returns
Goldman Sachs Alexis Wilson-Elizondo, Co-Head of Global Multi-Asset Solutions and Co-Chief Investment Officer, said the market is punishing megacap companies due to uncertainty surrounding the return
-
Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO
Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases, is seeking to raise as much as $212.5 million in a US initial public offering. The company is backed by Go
-
Goldman Sachs: Trading Congestion in AI Stocks Falls to a Near-One-Year Low; Market Focus Shifts to Fundamentals
Goldman Sachs Traders noted that trading congestion in global AI-related stocks has fallen to a near one-year low following a round of sharp deleveraging. Goldman Sachs Prime Brokerage data shows that
-
Goldman Sachs: Fed's Decision Today Could Be Largest 'Surprise' Since 1997
Goldman Sachs stated that whatever the U.S. Federal Reserve decides today will mark the largest "surprise" at a non-rate-cut meeting since 1997. This assessment comes as interest-rate futures markets
-
Former Goldman Sachs Banker Berko on Trial for Allegedly Paying Bribes in Ghana
A former Goldman Sachs Group Inc. banker went on trial Tuesday in the US for allegedly paying Ghanaian government officials a “holy rain” of bribes. The bribes were reportedly to secure a lucrative po
-
Goldman Sachs Predicts Big Tech Will Fund Over a Third of AI Investments with Debt by 2027
Goldman Sachs predicts that by 2027, major tech companies, or "hyperscalers," will fund over a third of their artificial intelligence (AI) investments with debt. The firm expects these companies to is
-
Goldman Sachs: Global Hedge Funds Post 7% H1 Returns, Poised for Stellar Year on AI Boom
Global hedge funds returned an average of 7% in the first half of 2026, significantly outperforming their 10-year average of 4.1%, according to a Goldman Sachs report. The bank attributes this strong
-
Goldman Sachs Warns of Rising Macro Risks, Raises US & European Default Forecasts
Goldman Sachs has warned that rising oil volatility is shifting investor focus from company earnings to broader macro risks, including inflation and higher interest rates. The bank expects the Federal
-
Oil Startup Backed by Ex-Goldman Commodity Chief Jeff Currie to IPO in London, Seeking $67 Million
An oil startup backed by Jeff Currie, former Goldman Sachs Group Inc. commodities chief, is preparing to raise £50 million ($67 million) through a London stock market listing. The funds are intended t
-
JPMorgan and Goldman Sachs CEOs Express Caution Despite Record Quarters
JPMorgan and Goldman Sachs recently reported record-breaking quarterly results. However, the CEOs of both firms have expressed uncertainty about the sustainability of these strong performances.
-
Goldman Sachs maintains Q3 2026 TTF gas forecast at €60/MWh, warns of upside risks
Goldman Sachs maintained its Q3 2026 TTF gas forecast at €60/MWh, but noted that risks remain skewed to the upside. The firm indicated that if U.S.-Iran talks succeed, prices could fall below €50/MWh.
-
Goldman Sachs CEO: Supports Advancing the CLARITY Act; the Bill Is Not Perfect
Svmuu News: David Solomon, CEO of Goldman Sachs, expressed support for advancing the CLARITY Act, while acknowledging that the legislation “is not perfect.” His remarks contrast with criticism from JP
-
Goldman Sachs Expressed support for the CLARITY Act, stating that it will establish a fair regulatory framework for the crypto market
Svmuu News Goldman Sachs Group CEO David Solomon stated that although the CLARITY Act is not perfect, he supports its passage, believing it will establish a clearer and fairer regulatory framework for
-
Goldman Sachs: If the Strait of Hormuz remains blocked, Brent crude could rise above $120 in the fourth quarter
Svmuu News Goldman Sachs The group released a report stating that if disruptions in the Strait of Hormuz continue, Brent crude prices could rise above $120 per barrel in the fourth quarter. However, G
-
Goldman Sachs: Hedge Funds Are Dumping U.S. Tech Stocks at a Record Pace
Svmuu News: According to market reports, Goldman Sachs states that hedge funds are selling off U.S. tech stocks at a record pace. (Jin Shi)
-
Spot gold has fallen back below $3,970 per ounce
Svmuu News: According to Gate data, spot gold has fallen back below $3,970 per ounce, down 0.16% on the day. Goldman Sachspreviously noted that, despite pressure from expectations of a hawkish Federal
-
Goldman Sachs: Central Bank Buying Will Support Gold Prices
Svmuu News Goldman Sachs reports that, despite pressure from expectations of a hawkish Federal Reserve, central bank buying is expected to provide support for gold prices.Demand remains strong; accord
-
Goldman Sachs U.S. stocks are expected to see a strong earnings season, with second-quarter earnings for S&P 500 components set to surge 22% year-over-year.
Svmuu News: According to Goldman Sachs, the U.S. stock market is set to see another strong earnings season. Goldman Sachs Earnings for S&P 500 components are projected to surge 22% year-over-year in t
-
Goldman Sachs Robinhood's target price raised to $137
Svmuu News: Goldman Sachs has raised its price target for Robinhood from $121 to $137 and maintained its “Buy” rating.
- No data
Goldman Sachs
24H Trending
-
1
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
4
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
5
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
9
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
10
TRIVIA Coin: Originally Designed to Create a Blockchain-Based Trivia Game—Analysis of Current Market Performance and Project Status
Markets Today
Recommended Reading






